The event is being held Thursday, June 13, 2024 from 8 a.m. to 12:30 p.m. in Hofheimer Hall Auditorium. It will be livestreamed via Zoom for those who will be unable to attend in-person. Download the 2024 Resident Research Day program.
Schedule of Events
2024 Mason C. Andrews, MD, Resident Research Day Schedule
Opening Remarks
Time: 8 a.m. to 8:10 a.m.
Speaker: George Saade, MD, Chairman, Obstetrics and Gynecology
Sue Kelly Sayegh, MD, Memorial Lecture
Time: 8:10 a.m. to 9 a.m.
Speaker: Katherine Laughon Grantz, MD, MPH, Vice Chair of Research Professor, Department of Women’s Health Principal Investigator, the Maternal-Fetal Medicine Units Network Columbia University
The Mason C. Andrews Endowed Lecture
Title: Defining Normal and Abnormal Fetal Growth: Is the Hadlock Reference Obsolete?
Presentations
Nine (9) residents from our program will present their research from 9 a.m. through 12:05 p.m. There will be a short break from 10:15 a.m. to 10:45 a.m.
Use the accordions (click + to the right of presenter name) below to learn more about the residents and their research.
Time: 9 a.m. to 9:20 a.m.
Title: Cash Rules Everything Around Me? Impact of Financial Penalties on Appointment Non-Adherence in Academic Obstetrics and Gynecology Clinic
Presenter: Lauren Forbes, MD, PGY-3
Mentor: Peter Takacs, MD
Abstract
Objective
To examine the impact of patient financial penalties on appointment non-adherence within a single academic institution's obstetrics and gynecology (OBGYN) outpatient clinics.
Methods
This retrospective policy effectiveness-implement at our institution's OBGYN outpatient clinics from May 1, 2018 to April 30, 2022. The institution-wide patient financial penalty policy for appointment non-adherence was implemented on May 1, 2020. We conducted an interrupted time series analysis (ITS) stratified by clinic and insurance after adjusting for the effect of COVID-19.
Results
There were 414,006 OBGYN outpatient clinic appointments; 58,473 (14.1%) were not attended. The mean (standard deviation) per month was 8391 (727) appointments and 14.3%
(1.48%) non-adherence rate. Medicare/Medicaid patients had a higher non-adherence rate (36,872/188,343 [19.6%]).
COVID-19 was a significant confounder across all clinics and insurances. Adjusted ITS models observed a significant sustained effect on number of non-adherent appointments per month
(+0.18; p<0.01). Stratified by clinic, maternal-fetal medicine (-1.47; p=0.01), minimally invasive gynecology (+4.62; p<0.01), and urogynecology (+4.42; p=0.01), observed a significant immediate effect. Maternal-fetal medicine (+0.09; p=0.02) and generalists (-0.33; p<0.01) observed a significant sustained effect.
Stratified by insurance, publicly insured patients (-3.99; p=0.048) observed a significant immediate effect. Publicly (+0.21; p<0.01) and non-publicly (+0.09; p=0.03) insured patients
observed a significant sustained effect.
Conclusion
A clinically significant reduction in appointment non-adherence was not observed in OBGYN outpatient clinics after institutional implementation of patient financial penalties
for appointment non-adherence. The impact of these penalties may differ based on clinic or patient insurance type.
Time: 9:20 a.m. to 9:35 a.m.
Title: First Documented Case of Recurrent Non-Immune Hydrops (NIH) Attributable to TRAPPC11-Associated Congenital Glycosylation Disorder (CGD)
Presenter: Salimah Navaz Gangji, MD, PGY-1 C
Mentors: Camille Kanaan, MD, Tetsuya Kawakita, MD
Abstract
Background
NIH is a heterogeneous disorder affecting approximately 1 in 4,000 pregnancies. Recurrence in consecutive pregnancies is exceedingly rare. CGD’s represent a rare subset of
metabolic genetic conditions that contribute to NIH.
Case
A 20-year-old G2P0100 previously experienced intrauterine fetal demise (IUFD) at 21 weeks due to NIH. In her subsequent pregnancy, the fetus was again diagnosed with NIH at 21 weeks, with minimal improvement in anemia despite intravenous immunoglobulin and percutaneous umbilical blood sampling (PUBS). Comprehensive evaluations ruled out infectious, viral, and hemoglobinopathy causes for both pregnancies. The G2 infant delivered via emergentcesarean section at 31 weeks due to terminal bradycardia following PUBS. Whole genome sequencing identified a pathogenic maternal TRAPPC11 gene mutation and a paternally inheritedvariant of uncertain significance (VUS) in the same gene. The VUS has been observed in ahomozygous or compound heterozygous state in other affected individuals, suggesting its deleterious potential. The same TRAPPC11 variants were also found in the G1 infant as well. The G2 infant exhibited symptoms consistent with muscular dystrophy including global hypotonia,diminished hemidiaphragm movement, persistently elevated creatine phosphokinase, sustaineddependence on respiratory support. Its cerebellar abnormalities and hypertrophic
cardiomyopathy were also consistent with phenotypes observed in CGD-related NIH.
Conclusion
This case represents the first documented instance of recurrent NIH attributed to a compound heterozygous mutation in TRAPPC11, highlighting a novel genetic etiology for NIH associated with a glycosylation disorder and underscoring the importance of considering genetic contributions in recurrent NIH cases due to their effect on fetal development.
Time: 9:35 a.m. to 9:55 a.m.
Title: Rate of Deterioration of Umbilical Artery Doppler Indices in Fetuses with Severe Early-Onset Fetal Growth Restriction
Author: Lindsay Gould, MD, PGY-3
Mentors: Juliana Gevaerd Martins, MD
Abstract
Objective
To examine risk factors for the development of absent or reversed end-diastolic velocity (A/REDV) in the umbilical artery (UA) and time intervals of deterioration from normal UA Doppler indices (systole/diastole ratio [S/D], pulsatility [PI], or resistance [RI]) to decreased (DEDV) and A/REDV.
Methods
Retrospective cohort study from 2005 to 2020, included all singleton pregnancies with severe (estimated fetal weight [EFW] below the third percentile) and early-onset (diagnosed between 20 to 32 weeks of gestation) fetal growth restriction (FGR). EFW and Doppler indices were reviewed longitudinally from diagnosis to delivery. Backward stepwise logistic regression was performed to calculate odds ratios with 95% confidence intervals.
Results
985 patients were included, 79 (8%) progressed to A/REDV. Gestational age at diagnosis and chronic hypertension were associated with progression to A/REDV. Rates of progression with normal UA Doppler to A/REDV were significant after 4 weeks from diagnosis. Rate of progression from normal to abnormal S/D ratio compared to PI or RI was higher at 4 and 6 weeks. Deterioration from abnormal indices to A/REDV was shorter with abnormal RI and PI when compared with the S/D at 2, 4, and 6 weeks after diagnosis and at 6 weeks, respectively
Conclusion
With normal Doppler indices, significant deterioration and progression to A/REDV is unlikely until 4 weeks after diagnosis. Abnormal S/D seems to appear first. However, abnormal PI or RI was associated with A/REDV.
Time: 9:55 a.m. to 10:15 a.m.
Title: Third Trimester Fetal Growth Ultrasound in Obese Patients for the Detection of Growth Abnormalities
Author: Elizabeth Miller, MD, PGY-3
Mentor: Tetsuya Kawakita, MD, , Rebecca Horgan, MD, Juliana Martins, MD
Abstract
Objective
To externally validate a prediction model that detects severe post-cesarean anemia.
Methods
This was a retrospective cohort study of all individuals undergoing cesarean delivery at Sentara Norfolk General Hospital in 2020. Previously published postoperative hemoglobin level calculator included preoperative hemoglobin level, preoperative platelet level, quantitative blood loss, height, weight, magnesium administration, labor, and general anesthesia. These variables were used in the established model to predict severe post-cesarean anemia (post-cesarean day 1 hemoglobin <7.0g/dL). Individuals who had missing data or those who had transfusions before and during cesarean delivery were excluded. A receiver operating characteristic (ROC) curve with the area under a curve (AUC) was created. We calculated the sensitivity and specificity of the model.
Results
Of 1222 individuals, 26 (2.1%) had post-cesarean severe anemia. The prediction model had an AUC of 0.90 (95% confidence interval 0.82-0.97). Using the best cutoff hemoglobin of 8.57g/dL, 221 (18.1%) were identified as high-risk for severe post-cesarean anemia. The sensitivity and specificity of the prediction model were 80.8% and 83.3%, respectively. The model had positive and negative predictive values of 9.5% and 99.5%, respectively.
Conclusion
The previously published prediction model was externally validated within our cohort and identified individuals who were at high risk for severe post-cesarean anemia. Using this model, we could avoid unnecessary postoperative laboratory tests, allowing more judicious use of healthcare resources and decreased spending.
Time: 10:45 a.m. to 11:05 a.m.
Title: Rates of Chorioamnionitis in Patients Undergoing Induction of Labor with Oxytocin versus Prostaglandin for Premature
Rupture of Membranes
Presenter: Madison Seward, MD, PGY-3
Mentor: Tetsuya Kawakita, MD
Abstract
Objective
To examine the rates of chorioamnionitis in patients with term premature rupture of membranes (PROM) undergoing labor induction with oxytocin versus prostaglandin.
Methods
This was a secondary analysis of the Consortium on Safe Labor (CSL) from 2002 to 2008 across the US. The analysis was limited to individuals at term ( 37 weeks) with singleton pregnancies, cephalic presentation, and unfavorable cervix who underwent induction of labor for PROM. Individuals were categorized based on the induction methods (either oxytocin or prostaglandins). Our primary maternal outcome is the rate of intrapartum chorioamnionitis. Secondary outcomes included cesarean delivery and neonatal intensive care unit (NICU) admission. Multivariable logistic regression was used to calculate adjusted odds ratios (aOR) with 95% confidence intervals (95%CI), accounting for confounders and the clustering effect of sites.
Results
Of 1,250 individuals with term PROM, 133 underwent induction with prostaglandins and 1117 underwent induction with Oxytocin. Compared to induction with Oxytocin, prostaglandin was associated with lower odds of intrapartum chorioamnionitis (11.8% vs. 2.3%; aOR 0.24; 95%CI 0.14-0.39) and was associated with higher odds of cesarean delivery (22.5% vs.33.8%; aOR 1.98; 95%CI 1.07-3.68). There was no significant difference in NICU admission (4.7% vs. 5.3%; aOR 1.06; 95% 0.40-2.82).
Conclusion
In individuals with term PROM, induction of labor by prostaglandins was associated with decreased odds of intrapartum chorioamnionitis but was associated with increased odds of cesarean delivery.
Time: 11:05 a.m. to 11:20 a.m.
Title: Case Report: Surgical Management of a Cesarean Scar Ectopic Pregnancy
Author: Sarah Hinson, MD, PGY-1
Mentors: Jeffrey Woo, MD
Abstract
Background
Ectopic pregnancy is characterized by implantation of a fertilized egg outside of the uterine cavity. While most ectopic pregnancies occur in the fallopian tube, implantation can also occur in other locations such as the abdomen, cervix, ovary, or a cesarean scar. Management options include medical, surgical, or expectant management based on patient preference and clinical status.
Case
A 27-year-old G2P0101 with a history of one prior cesarean section presented to the emergency department with vaginal bleeding and a positive pregnancy test. Ultrasound revealed a gestational sac and fetal pole approximately 6 weeks 5 days gestation in the upper cervix/lower uterine segment, suggestive of a cesarean scar ectopic pregnancy. The patient opted for surgical management and underwent robot-assisted laparoscopic excision of the ectopic pregnancy.
In the operating room, the pregnancy was identified, and the vesico-vaginal space was developed. Uterine and ovarian arteries were clamped with Bulldog clamps, and vasopressin was injected adjacent to the pregnancy. Monopolar scissors were then used for excision. The lower uterine segment was reapproximated with 2-0 V-lock suture, and a uterine sound was utilized to ensure cervical canal patency. Minimal blood loss was observed during the procedure.
Conclusion
Ectopic pregnancies outside of the fallopian tube can present challenges due to delayed diagnosis and treatment. This case highlights the use of meticulous surgical techniques to minimize blood loss and intraoperative complications while preserving long-term fertility outcomes.
Time: 11:20 a.m. to 11:35 a.m.
Title: Case Report: Ureteral Injury Following Perforation by IUD
Author: Manasi Mahashabde, MD, PGY-1
Mentor: R. Kate Byron, MD
Abstract
Background
Overall risk of uterine perforation is 0.3-2.6 per 1000 IUD insertions. Regardless of IUD type, the perforation risk is higher within one year postpartum, particularly within six weeks. The following case is one of few perforations in the literature involving severe renal compromise.
Case
A 32-year old G2P1011 previously healthy female presented to the emergency department reporting nausea/vomiting for 11 days and subjective fevers. Evaluation revealed tachycardia, leukocytosis, elevated lactate, and CT findings of left-sided hydronephrosis/ureter with transition point adjacent to an IUD protruding from the uterine fundus. The patient reported delayed postpartum IUD placement following cesarean delivery 7 years prior, with short interval ultrasound confirming placement. Interestingly, her strings were visible at the cervical os on admission exam. A pelvic ultrasound showed distal IUD arms protruding from the left myometrium with an adjacent tubular hypoechoic structure, resembling a dilated ureter. The patient was admitted for percutaneous nephrostomy tube (PCNT) placement and IV antibiotics. PCNT output was culture positive for Citrobacter koseri, supporting the diagnosis of urosepsis.
Although the patient had no underlying renal disease and normal creatinine, a nuclear renogram demonstrated no residual left kidney function. Urology recommended interval robotic left nephrectomy. Concurrent IUD removal is planned
Conclusion
The CDC does not recommend routine exams following IUD insertion given lack of data demonstrating effectiveness in reducing complications of IUD malposition, including uterine perforation. The above case demonstrates the importance of imaging in the identification of IUD malposition, given the patient’s normal pelvic exam.
Time: 11:30 a.m. – 11:45 a.m.
Title: Spontaneous Endometrioma Rupture in Disguise
Author: Lea Nehme, MD, PG-1
Mentor: Joseph Hudgens, MD
Abstract
Background
Rupture of endometriotic ovarian cysts is a rare occurrence, affecting less than 3% of those diagnosed with endometriosis, its potential ramifications are severe, including acute peritonitis, sepsis, and septic shock. In this case series, we shed light on two instances of spontaneous endometrioma rupture emphasizing the critical importance of timely recognition and intervention.
Case
A 30-year-old woman presented to the emergency department with worsening pelvic pain. Vitals were stable except for tachycardia and her labs revealed a slightly elevated white blood cellcount. CT scan reported an 11 cm complex tubular cystic structure in adnexa. Due to worsening clinical status with worsening pain, guarding, and rebound tenderness patient underwent adiagnostic laparoscopy for a suspected tubo-ovarian abscess. Upon entry, a spontaneously ruptured endometrioma of the right ovary was noted.
A 48-year-old woman presented to the emergency department with months of pelvic pain and a known history of endometriosis. Findings on the imaging were suggestive of advanced pelvic malignancy and progressive carcinomatosis. Patient was admitted for surgical planning and tissue sampling. CA-125 was 95. Interventional Radiology attempted to obtain a biopsy; however, results were inconclusive with few atypical cells. Patient then underwent a diagnostic laparoscopy. Upon inspection extensive adhesive disease was noted due to stage IV endometriosis. Pathology results and pelvic washings revealed no malignancy.
Conclusion
hese cases highlight the ongoing challenges in diagnosing ruptured endometriomas and the necessity for comprehensive care to improve the overall well-being of individuals affected by this condition
Time: 11:50 a.m. – 12:05 p.m.
Title: Case Report: Severe Fetal Growth Restriction Following Salpingo-Oophorectomy in Pregnancy
Author: Anita Pershad, MD, PGY-1
Mentor: Andrew Moore, MD
Abstract
Background
Prior literature has shown that the corpus luteum makes progesterone in early pregnancy, until week 13, when the placenta takes over progesterone production for pregnancy support. Progesterone is thought to maintain a quiet, non-contractile uterus by virtue of its antiinflammatory and immunosuppressive properties. Laparoscopic surgery in pregnancy is generally thought to be safe for mother and fetus, with minimal risks, and should not be delayed in emergent circumstances.
Case
AAn 18-year-old G1P0 with intrauterine pregnancy at 19 weeks and 6 days gestation presented with acute left lower quadrant abdominal pain in the setting of a 12 cm left ovarian cyst. She underwent a diagnostic laparoscopy with left ovarian cystectomy and left salpingooophorectomy. The surgery was uncomplicated, and pathology revealed benign fallopian tube, ovary, and cyst wall consistent with torsion. At her subsequent ultrasound, she was noted to have severe fetal growth restriction with estimated fetal weight <1%ile. Her pregnancy was otherwise uncomplicated with no maternal co-morbidity to explain the intrauterine growth restriction. Previous ultrasounds showed a normally grown fetus with estimated fetal weight measuring in the 29%Iie. She underwent induction of labor at 38 weeks for severe fetal growth restriction anddelivered a baby girl weighing 1995g.
Conclusion
This case suggests that the ovary and corpus luteum may play a role in progesterone production and placental support at a later gestational age than previously thought. We are not aware of any previously reported case of new onset of fetal growth restriction afterunilateral salpingo-oophorectomy in pregnancy.
Closing Remarks & Adjournment
Time: 12:05-12:25 p.m.